연구동향 분석

Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study

Jae Yoon Jeong Dae Won Jun Sol Ji Park Joo Hyun Sohn Sang Gyune Kim Se Whan Lee Soung Won Jeong Moon Young Kim Won Kim Jae-Jun Shim Hyoung Su Kim Ki Tae Suk Sang Bong Ahn 2020년

논문상세정보
인용/피인용
' Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Sustained virologic response
  • chronic hepatitis c
  • vitamin d
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
276 0

0.0%

' Effects of vitamin D supplements in patients with chronic hepatitis C: a randomized, multi-center, open label study' 의 참고문헌

  • Vitamin D supplementation improves sustained virologic response in chronic hepatitis C(genotype 1)-naive patients
    Abu-Mouch S [2011]
  • Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients : a randomized, double-blind, placebo-controlled study
    Komolmit P [2017]
  • Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C
    Bitetto D [2011]
  • Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C : a systematic review and meta-analysis
    Kitson MT [2014]
  • Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats
  • Vitamin D in chronic liver disease
    Stokes CS [2013]
  • Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients
    Nimer A [2012]
  • Vitamin D for your patients with chronic hepatitis C
    Rahman AH [2013]
  • Vitamin D deficiency in older men
    Orwoll E [2009]
  • Vitamin D deficiency in non-alcoholic fatty liver disease : the chicken or the egg
    Lee SM [2017]
  • Vitamin D deficiency in Europe : pandemic
    Cashman KD [2016]
  • Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy
    Lange CM [2011]
  • Vitamin D and parathyroid hormone in outpatients with noncholestatic chronic liver disease
    Fisher L [2007]
  • Vitamin D : importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis
    Holick MF [2004]
  • Vitamin D : an innate antiviral agent suppressing hepatitis C virus in human hepatocytes
  • Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response
    Liu PT [2006]
  • The prevalence of vitamin D inadequacy amongst women with osteoporosis : an international epidemiological investigation
    Lips P [2006]
  • The 2011 report on dietary reference intakes for calcium and vitamin D
    Ross AC [2011]
  • Serum levels of soluble tumor necrosis factor receptors and effects of interferon therapy in patients with chronic hepatitis C virus infection
    Itoh Y [1999]
  • Serum concentrations of vitamin D and parathyroid hormone and prevalent metabolic syndrome among adults in the United States
    Ford ES [2009]
  • Serum 25-hydroxyvitamin D and metabolic syndrome in a Japanese working population : the Furukawa Nutrition and Health Study
    Akter S [2017]
  • Role of chemokines and their receptors in viral persistence and liver damage during chronic hepatitis C virus infection
    Larrubia JR [2008]
  • Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy : a meta-analysis
  • Prospective study of predictors of vitamin D status and cancer incidence and mortality in men
  • Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy
    Holick MF [2005]
  • Prevalence and correlates of vitamin D deficiency in US adults
    Forrest KY [2011]
  • Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals
    Lu L [2009]
  • Low vitamin D serum level is related to severe fibrosis and low responsiveness to interferon-based therapy in genotype 1 chronic hepatitis C
    Petta S [2010]
  • KASL clinical practice guidelines: management of hepatitis C
  • Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin
    Grasso A [2009]
  • Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality
    Dobnig H [2008]
  • Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin
    Esmat G [2015]
  • Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection:a meta-analysis of randomised controlled trials
    Kim HB [2018]
  • Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b : a randomized controlled trial
    Yokoyama S [2014]
  • Concentrations of serum vitamin D and the metabolic syndrome among U. S. adults
    Ford ES [2005]
  • 25-Vitamin D levels in chronic hepatitis C infection : association with cirrhosis and sustained virologic response
    Backstedt D [2017]